Yongkang Nuoao Trading Co
Finnrick has tested 9 samples from Yongkang Nuoao Trading Co across 2 products.
Finnrick Vendor Profile
Yongkang Nuoao Trading Co
Tracking 2 products
9 total samples tested
Last test 3 Mar 2026
Take Action
Test My Sample
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Retatrutide | 8 | 25 Jul 2025 | 3 Mar 2026 | |||||
| Tirzepatide | 1 | 11 Jun 2025 | 11 Jun 2025 | |||||
The Yongkang Nuoao Trading Co samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Most recent Yongkang Nuoao Trading Co tests
Samples are tested in commercial labs
9
tests
2
products
Scores
AVGMINMAX
First
11 Jun 2025
Last
3 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 3 Mar 2026 | Retatrutide | View | 10mg | 9.98mg | -0.2% | 98.86% | (no batch ID) | No Label / Silver Crimp / Clear Blue Cap | Lab E | Public | |
| 20 Feb 2026 | Retatrutide | View | 50mg | 56mg | +12.0% | 99.80% | (no batch ID) | No Label / Black Crimp / Clear Purple Cap | Lab G | Public | |
| 18 Feb 2026 | Retatrutide | View | 20mg | 33.7mg | +68.5% | 99.68% | 12/5/2025 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 7 Jan 2026 | Retatrutide | View | 5mg | 4.9mg | -2.0% | 99.70% | (no batch ID) | No Label / Silver Crimp / White Cap | Lab G | Public | |
| 29 Dec 2025 | Retatrutide | View | 15mg | 15.6mg | +4.0% | 99.80% | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab G | Public | |
| 29 Oct 2025 | Retatrutide | View | 15mg | 14.3mg | -4.7% | 99.95% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |
| 21 Aug 2025 | Retatrutide | View | 15mg | 14.5mg | -3.3% | 99.91% | (no batch ID) | No Label / Silver Crimp / Red Cap | Lab E | Public | |